Youngdahl to switch retiring Glenn Kues
San Antonio, Texas, July 06, 2022 (World NEWSWIRE) — BioBridge World, a San Antonio-based nonprofit healthcare services enterprise, integrating donor-to-client companies to enable the upcoming of biotherapeutic options, introduced today that it has named John Youngdahl MBA as Senior Vice President and Chief Economic Officer, successful instantly.
Youngdahl has been with the company given that December 2016, serving as Government Director of Monetary Organizing and Evaluation. He succeeds Glenn Kues CPA, who has served as Senior Vice President and Main Fiscal Officer because December 2017. Kues retired June 30.
Youngdahl held senior economic positions in Arjo-Huntleigh – Getinge AB, Kinetic Principles Inc. (now 3M/KCI) and Dell Economical Companies. He attained a Bachelor of Arts diploma in finance from Gustavus Adolphus Faculty in St. Peter, Minnesota, and an MBA from Texas Point out University.
“We are quite fortunate to have a particular person of John’s knowledge and high quality prepared to direct our Money and Information Providers capabilities,” mentioned Martin Landon, CEO of BioBridge World.
“At the identical time, the complete corporation would like to thank Glenn for his management and contributions, which include the improvement of John and other customers of the workforce, all through this earlier 4½ years. We want him and his family members all the most effective in his retirement yrs.”
# # #
About BioBridge Worldwide: BioBridge Global is a San Antonio-based 501(c)(3) nonprofit regenerative drugs organization that provides diverse providers via its 4 subsidiaries – South Texas Blood & Tissue, QualTex Laboratories, GenCure and The Blood & Tissue Center Foundation. BBG provides solutions and products and services in blood source management, mobile remedy, donated umbilical twine blood and human tissue, as nicely as, tests of blood, plasma and tissue products for customers in the United States and around the world. BBG is committed to saving and maximizing life by means of the healing ability of human cells and tissue. It allows developments in the subject of regenerative medicine by providing obtain to human cells and tissue, screening expert services and biomanufacturing and scientific trials assist. Find out far more at BioBridgeGlobal.org
Make contact with: Mary Uhlig Biobridge World-wide 210-731-5519 [email protected]